INHIBITION OF GROWTH BY THE ANTIHORMONE RU486 IN DIFFERENT HEPATOMA-CELL LINES

被引:4
作者
CHASSEROTGOLAZ, S [1 ]
BECK, G [1 ]
VENETIANER, A [1 ]
机构
[1] BIOL RES CTR,INST GENET,H-6701 SZEGED,HUNGARY
基金
匈牙利科学研究基金会;
关键词
ANTIGLUCOCORTICOID; METABOLIZATION; ANTIPROLIFERATIVE EFFECT; GLUCOCORTICOID RECEPTOR;
D O I
10.1016/0303-7207(91)90026-O
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The synthetic steroid RU486 (17-beta-hydroxy-11-beta-(4-dimethylaminophenyl)-17-alpha-(1-propynyl)-estra-4,9-dien-3-one), which has been shown to display antiprogestin and antiglucocorticoid properties in different systems, exerts antiglucocorticoid effects and inhibits the cell growth in a concentration-dependent manner on Reuber rat hepatoma cell variants. This effect can be observed on glucocorticoid-sensitive cells, containing glucocorticoid receptors, and on glucocorticoid-resistant cells displaying a very low level of dexamethasone binding. Metabolization of RU486 occurs in different glucocorticoid-resistant hepatoma variants; these cells are less sensitive to the growth inhibitory effect of the antihormone than the steroid-sensitive cells which do not metabolize RU486. Thus, metabolization of RU486 must also be taken into account for the efficacy of this antagonist on cell growth.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 23 条